Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aerpio Pharmaceuticals Inc (NQ: ARPO )

1.470 USD UNCHANGED
Streaming Delayed Price Updated: 2:32 PM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Aerpio Pharmaceuticals Inc

< Previous 1 2 3 4 5 6 Next >
The Daily Biotech Pulse: FDA Nod For Sage's Postpartum Depression Drug, Pfizer Invests In Gene Therapy Company
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags PRNB DERM ABT
From Benzinga
The Daily Biotech Pulse: FDA Nod For Roche And Amphastar, Milestone Payment Kicks In For Affimed
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags INNT Market News Top Stories
From Benzinga
60 Biggest Movers From Yesterday
Gainers Dare Bioscience Inc (NASDAQ: DARE) shares climbed 131.11 percent to close at $2.10 on Monday after the company published ... 
Tags General OGEN VTVT
From Benzinga
Mid-Afternoon Market Update: Crude Oil Up 1%; Dare Bioscience Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 0.1 percent to 25,875.10 while the NASDAQ climbed 0.23 percent to 7,705.94. The ... 
Tags ARPO DERM PHAS
From Benzinga
48 Stocks Moving In Monday's Mid-Day Session
Gainers Dare Bioscience Inc (NASDAQ: DARE) shares surged 125.8 percent to $2.0317 after the company published positive clinical ... 
Tags DERM SIEN PHAS
From Benzinga
Mid-Day Market Update: FutureFuel Falls After Q4 Results; Dermira Shares Jump
Midway through trading Monday, the Dow traded down 0.15 percent to 25,809.65 while the NASDAQ declined 0.06 percent to 7,684.03. The ... 
Tags PHAS ARPO DERM
From Benzinga
Mid-Morning Market Update: Markets Edge Higher; Fidelity National To Buy Worldpay
Following the market opening Monday, the Dow traded up 0.04 percent to 25,860.01 while the NASDAQ climbed 0.49 percent to 7,726.29. The ... 
Tags PHAS DERM ARPO
From Benzinga
Aerpio Pharmaceuticals Announces Results From TIME-2b Study of AKB-9778 in Diabetic Retinopathy
Aerpio Pharmaceuticals, Inc. (Nasdaq:ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced top-line... 
From Business Wire News Releases
70 Biggest Movers From Friday
Gainers AquaBounty Technologies, Inc. (NASDAQ: AQB) shares surged 118.3 percent to close at $4.89. AquaBounty Technologies ... 
Tags MAG MTN Movers
From Benzinga
The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags STIM SEEL KURA
From Benzinga
Aerpio Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
Aerpio Pharmaceuticals, Inc. (Nasdaq:ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today reported financial... 
From Business Wire News Releases
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs
It was an event-filled one for biotech stocks, with the release of a slew of earnings, presentations of clinical trial results and ... 
Tags News OTIC ACRX
From Benzinga
72 Biggest Movers From Yesterday
Gainers FTE Networks Inc (NYSE: FTNW) shares climbed 112.84 percent to close at $2.32 on Tuesday after the company said it won ... 
Tags AMR Losers FTCH
From Benzinga
Aerpio Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, March 5, 2019
Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced that its... 
From Business Wire News Releases
71 Biggest Movers From Yesterday
Gainers Riot Blockchain, Inc. (NASDAQ: RIOT) shares gained 34.82 percent to close at $3.33 on Tuesday amid strength in the ... 
Tags Movers & Shakers Benzinga WBAI
From Benzinga
54 Stocks Moving In Tuesday's Mid-Day Session
Gainers Riot Blockchain, Inc. (NASDAQ: RIOT) shares climbed 30.5 percent to $3.2224 amid strength in the cryptocurrency ... 
Tags PCMI Cryptocurrency EYEN
From Benzinga
64 Biggest Movers From Yesterday
Gainers Fortress Biotech (NASDAQ: FBIO) shares gained 39.86 percent to close at $2.07 after the company highlighted a ... 
Tags News Pre/Market Outlook MGTX
From Benzinga
Aerpio Pharmaceuticals Announces Completion of Patient Dosing in TIME-2b Study of AKB-9778 in Diabetic Retinopathy
Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced the... 
From Business Wire News Releases
44 Biggest Movers From Friday
Gainers Flotek Industries, Inc. (NYSE: FTK) shares climbed 95.74 percent to close at $2.76 on Friday after the company reported ... 
Tags VSTM GOL Losers
From Benzinga
58 Biggest Movers From Yesterday
Gainers CLPS Incorporation (NASDAQ: CLPS) shares surged 100.32 percent to close at $6.35 on Tuesday. VirnetX Holding Corp (NYSE: ... 
Tags TLRY Market News CKPT
From Benzinga
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
After extended weakness, biotech stocks turned a corner along with the broader markets to close out the week. With just a session left, ... 
Tags MRNS Market News Top Stories
From Benzinga
The Daily Biotech Pulse: Tracon Aces Early-Stage Trials, Boston Scientific To Buy Out Millipede
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peak (Biotech stocks hitting ... 
Tags GNMX ALPN ABIO
From Benzinga
The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags Biotech TENX XBI
From Benzinga
Recent Analysis Shows Atlas Financial, Royal Dutch Shell, Vaalco Energy, Myovant Sciences, Aerpio Pharmaceuticals, and Wheeler Real Estate Investment Trust Market Influences — Renewed Outlook, Key Dri
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Atlas Financial Holdings,... 
From GlobeNewswire News Releases
Aerpio Pharmaceuticals to Present at the Stifel 2018 Healthcare Conference
Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced that... 
From Business Wire News Releases
The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags NVLN EDIT GHDX
From Benzinga
Aerpio Reports Third Quarter 2018 Financial Results and Provides Business Update
Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today reported financial... 
From Business Wire News Releases
The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs
Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy ... 
Tags INSY IRWD PLXP
From Benzinga
Aerpio Pharmaceuticals to Announce Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, November 7, 2018
Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced that its... 
From Business Wire News Releases
The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price
Here's a roundup of top developments in the biotech space over the last 24 hours. None of the biotech stocks hit 52-week highs in ... 
Tags ASNS KURA GILD
From Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.